Your Medicare quality scores are built one refill at a time. The pharmacy your patients use decides whether you win.
The highest weighted measures in Medicare are tied to medication adherence. Every diabetes, blood pressure, and cholesterol patient who lapses at a chain pharmacy is a patient drifting off therapy, and MIPS and Star Ratings exist to track exactly that. Fairview Pharmacy holds an EQuIPP star rating of 5.00 from Elevate Provider Network, Quarter 4, 2025, across every one of those measures.
Why primary care carries the most adherence risk
A primary care panel touches every chronic measure Medicare weights most.
A cardiologist worries about anticoagulation. An endocrinologist worries about diabetes. You worry about all of it: the metformin, the lisinopril, the atorvastatin, the inhaler, often in the same patient on the same visit. Every one is a refill that can lapse, a prior authorization that can stall, a medication a patient can quietly abandon over cost. And every lapse flows into a quality measure attached to your practice.
You cannot follow each patient to the pharmacy counter for each medication. A high performing pharmacy can.
Primary care quality risk
Every abandoned refill moves a triple weighted number the wrong way.
Star Ratings adherence: MAD, MAH, MAC
The three triple weighted Part D adherence measures, diabetes, blood pressure, and cholesterol. A lapse on any one pulls the score down for every plan that patient belongs to.
Statin use in persons with diabetes (SUPD, MIPS #438)
Diabetic patients aged 40 to 75 are expected to be on a statin. Fairview's SUPD score for the closed 2025 measurement year is 96.3%, 52 of 54 patients, five stars. The patients in the remaining gap have no statin on file, which is a prescribing decision we cannot close from behind the counter, and we send prescribers the list of shared patients with no statin on file on request.
MIPS quality and cost, your full panel
Non adherent patients are associated with more strokes, infarcts, and admissions, which raise your MIPS cost score and erode the quality measures tied to your reimbursement. MIPS adjustments can reach up to 9 percent, a maximum.
Primary care carries the broadest adherence exposure of any specialty. A pharmacy partner that publishes all four of its measures reduces that exposure across the panel at once.
The liability between you and your scores
At a chain pharmacy, your patient is a number.
If a prescription hits a prior authorization, nobody resolves it. If they skip a refill, nobody calls. If cost scares them off, nobody tells you. You learn months later, after the lapse has already pulled down the measures that decide your pay.
That guesswork is a pharmacy gap, and it is a liability sitting between you and your quality scores.
EQuIPP verified, all four measures published
Fairview beats the state average on every measure your panel touches.
EQuIPP star measures, Elevate Provider Network. Quarter 4, 2025, closed measurement year.
- Blood pressure (RASA) PDC98.2%, 215 of 219 patients5 stars
- Cholesterol PDC97.2%, 246 of 253 patients5 stars
- Statin use in diabetes96.3%, 52 of 54 patients5 stars
- Diabetes PDC95.6%, 108 of 113 patients5 stars
EQuIPP star rating 5.00. Five stars on all four measures, every year since 2022.
Fairview's EQuIPP star measure performance, issued by Elevate Provider Network for the closed 2025 measurement year: Blood pressure (RASA) PDC 98.2%, 215 of 219 patients. Cholesterol PDC 97.2%, 246 of 253. Statin use in diabetes 96.3%, 52 of 54. Diabetes PDC 95.6%, 108 of 113. EQuIPP star rating 5.00. Five stars on all four measures, every year since 2022. Our livelihood depends on patient adherence, exactly like your value based contracts do.
EQuIPP performance metrics as of Quarter 4, 2025, Medicare Part D population, benchmarked against national pharmacy averages. These measures describe prescribing and dispensing patterns. Neither is a measure of health outcomes.
You prescribe.
E prescribe to Fairview. NCPDP 2515104, NPI 1144383613.
We fill same day.
We clear every prior authorization.
We monitor.
We watch every medication on the regimen and call before any refill lapses.
We report to you.
A one page PDC adherence report at day ninety, across all measures, for the patients you referred.
You reinforce.
You address adherence at the next visit, with real data.
Same day fills
Every prescription filled within 24 hours, no waiting.
100% prior authorization handling
We carry the full prior authorization burden for your staff.
Pill pack program
Diabetes, blood pressure, and statin refills in one synced regimen, especially valuable for patients on five or more medications.
A one page report at day ninety
Who is on track and who is not, delivered at day ninety.
Proactive refill calls
We reach patients 5 days before they run out.
Direct clinical line
Your patients call us about side effects and cost, not your nurses.
Start with 5, zero risk
Send us 5 of your hardest chronic disease patients. 90 days. Zero risk.
We resolve the prior authorizations, keep them on therapy, and report adherence to your office at day ninety. No contract, no cost, and nothing owed in either direction. If the reports are not useful, tell us and we will change the format.
Request your intro call
A 10 minute call with Dr. Mike, no commitment and no paperwork to start. Just tell us how to reach you and a little about your practice. The 5 patient pilot is what we walk through on the call.
Typical response: Within 1 business day
Forms for referring practices